Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06514014 · ClinicalTrials.gov registry record · NA
Transition From Donor Milk: a Feasibility Study
A NA study of Preterm Birth and Nutrition, Healthy, sponsored by Augusta University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06514014: Recruiting NA study of Preterm Birth and Nutrition, Healthy, sponsored by Augusta University.
NCT06514014 is a NA study of Preterm Birth and Nutrition, Healthy that is actively recruiting participants, run by Augusta University. The registered enrollment target is 20 participants, below the 4,409-participant average among 39 other Preterm Birth trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06514014, a NA study of Preterm Birth and Nutrition, Healthy, is actively recruiting participants, sponsored by Augusta University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Preterm and very low birth weight (VLBW, \< 1,500g) infants who receive donor human milk (DHM) often experience slow postnatal growth and no clinical data is available to guide the duration of DHM for preterm infants. The investigators hypothesize that transitioning from DHM to preterm infant formula after the first month of life is both safe and conveys improved weight and length gains and fat free mass accumulation.
Primary Outcome
Weight velocity between birth and 36 weeks post menstrual age
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Preterm Infant Formula
Study Locations (1)
Georgia
- Wellstar-MCG - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT06514014 shows while recruiting
NCT06514014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 4,409-participant average among 39 other Preterm Birth trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Preterm Birth appearing as the primary indexed condition, and to 1 intervention - of which Preterm Infant Formula is the first listed.
NCT06514014 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06514014 about?
NCT06514014 is a clinical study titled "Transition From Donor Milk: a Feasibility Study". Preterm and very low birth weight (VLBW, \< 1,500g) infants who receive donor human milk (DHM) often experience slow postnatal growth and no clinical data is available to guide the duration of DHM for preterm infants. The investigators hypothesize that transitioning from DHM to preterm infant formul...
What is the current status of trial NCT06514014?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-05-01. Estimated completion is 2027-06-30.
What conditions does trial NCT06514014 study?
This clinical trial studies the following conditions: Preterm Birth, Nutrition, Healthy.
What interventions are being tested in trial NCT06514014?
The interventions under investigation include: Preterm Infant Formula (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06514014?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06514014 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06514014's enrollment target sits among peer trials
20 38th of 39 higher than 2 of 39 other Preterm Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
RECRUITING · NA
-
Stress Phenotypes and Preterm Birth
RECRUITING · NA
-
Optimal Timing of Routine Cervical Length Measurements During Anatomy Survey
RECRUITING · NA
-
Bilateral Infant Stimulation Study
RECRUITING · NA
-
Effect of Support for Low-Income Mothers of Preterm Infants
RECRUITING · NA
-
Sodium Awareness in Lactation Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI